These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7505905)

  • 1. Serum alpha 2-macroglobulin in haemodialysis patients: baseline and kinetic studies.
    Argilés A; Kerr PG; Mourad G; Mion CM; Atkins RC
    Nephrol Dial Transplant; 1993; 8(10):1118-23. PubMed ID: 7505905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta 2-microglobulin serum concentration and associated amyloidosis in dialysis patients.
    Stein G; Schneider A; Thoss K; Ritz E; Schaefer K; Hüller M; Sperschneider H; Marzoll I
    Nephrol Dial Transplant; 1991; 6 Suppl 3():57-61. PubMed ID: 1775270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous ambulatory peritoneal dialysis vs haemodialysis: a lesser risk of amyloidosis?
    Tielemans C; Dratwa M; Bergmann P; Goldman M; Flamion B; Collart F; Wens R
    Nephrol Dial Transplant; 1988; 3(3):291-4. PubMed ID: 3140103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies.
    Zingraff J; Beyne P; Ureña P; Uzan M; Nguyen Khoa Man ; Descamps-Latscha B; Drüeke T
    Nephrol Dial Transplant; 1988; 3(3):284-90. PubMed ID: 3140102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of serum levels of beta-2-microglobulin in dialysis patients].
    Baldrati L; Baldrati L; Delvecchio C; Capponcini C; Docci D; Turci F; Feletti C
    Recenti Prog Med; 1990 Sep; 81(9):561-3. PubMed ID: 2263750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis.
    Naganuma T; Sugimura K; Uchida J; Tashiro K; Yoshimura R; Takemoto Y; Nakatani T
    Nephrology (Carlton); 2008 Apr; 13(2):104-8. PubMed ID: 18275497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis related amyloidosis: a disease of chronic retention and inflammation?
    Floege J; Schäffer J; Koch KM; Shaldon S
    Kidney Int Suppl; 1992 Oct; 38():S78-85. PubMed ID: 1405384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mediators of amyloidogenesis and cytokines in dialysis-related amyloidosis].
    Rysavá R; Merta M; Tesar V; Lachmanová J; Sulková S; Bláha J
    Cas Lek Cesk; 2002 Apr; 141(8):244-7. PubMed ID: 12038073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
    Miyata T; Inagi R; Iida Y; Sato M; Yamada N; Oda O; Maeda K; Seo H
    J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of amyloidosis: a role for anti-proteases?].
    Argilés i Ciscart A; Mourad G
    Nephrologie; 1991; 12(2):51-4. PubMed ID: 1719439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodialysis-associated beta 2M amyloidosis: current controversies.
    Stein G; Sperschneider H; Fünfstück R; Ritz E
    Nephrol Dial Transplant; 1994; 9 Suppl 3():48-50. PubMed ID: 8072726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
    Gejyo F; Homma N; Arakawa M
    Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma kinetics of 125I-labelled amyloid P component in beta 2M amyloidosis: a possible approach to quantitate disease activity.
    Zingraff J; Caillat-Vigneron N; Ureña P; Gagné ER; Bererhi L; Moretti JL; Bardin T; Drüeke TB
    Nephrol Dial Transplant; 1995; 10(2):223-9. PubMed ID: 7753457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of novel beta 2-microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition.
    Ogawa H; Saito A; Oda O; Nakajima M; Chung TG
    Clin Nephrol; 1988 Sep; 30(3):158-63. PubMed ID: 3052955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal.
    Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S
    Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of habitual physical activity in chronic haemodialysis patients.
    Zamojska S; Szklarek M; Niewodniczy M; Nowicki M
    Nephrol Dial Transplant; 2006 May; 21(5):1323-7. PubMed ID: 16421165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of beta 2-microglobulin release from lymphocytes by dialysis membranes.
    Schaefer RM; Paczek L; Heidland A
    Nephrol Dial Transplant; 1991; 6 Suppl 3():53-6. PubMed ID: 1775269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 2-macroglobulin protects some of the protein constituents of dialysis-associated amyloidosis from protease degradation.
    Gouin-Charnet A; Mourad G; Argilés A
    Biochem Biophys Res Commun; 1997 Feb; 231(1):48-51. PubMed ID: 9070217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.